$ANTH Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Anthera Pharmaceuticals Inc.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Anthera Pharmaceuticals Inc. Get notifications about new insider transactions in Anthera Pharmaceuticals Inc for free.

Page: < prev 1 2 3 4 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 08 2013	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and CEO	Gift	G	0.00	66,412	0	691,537	625.1 K to 691.5 K (+10.62 %)
Jan 08 2013	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and CEO	Gift	G	0.00	66,412	0	0	66.4 K to 0 (-100.00 %)
Jan 08 2013	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and CEO	Payment of Exercise	F	0.69	17,454	12,043	66,412	83.9 K to 66.4 K (-20.81 %)
Jan 07 2013	ANTH	Anthera Pharmaceut ...	KILFOIL GEORGINA	SVP,Product Dev.& P ...	Payment of Exercise	F	0.69	2,410	1,663	30,035	32.4 K to 30 K (-7.43 %)
Jan 07 2013	ANTH	Anthera Pharmaceut ...	ODINK DEBRA	Chief Technology Of ...	Payment of Exercise	F	0.69	3,409	2,352	31,812	35.2 K to 31.8 K (-9.68 %)
Jan 07 2013	ANTH	Anthera Pharmaceut ...	Hislop Colin	Chief Medical Offic ...	Payment of Exercise	F	0.69	4,560	3,146	84,959	89.5 K to 85 K (-5.09 %)
Jan 07 2013	ANTH	Anthera Pharmaceut ...	LOWE CHRISTOPHER P.	C.F.O. and C.B.O.	Payment of Exercise	F	0.69	8,660	5,975	41,336	50 K to 41.3 K (-17.32 %)
Jul 03 2012	ANTH	Anthera Pharmaceut ...	KILFOIL GEORGINA	SVP,Product Dev.& P ...	Payment of Exercise	F	0.69	2,068	1,427	24,601	26.7 K to 24.6 K (-7.75 %)
Jul 03 2012	ANTH	Anthera Pharmaceut ...	ODINK DEBRA	Chief Technology Of ...	Payment of Exercise	F	0.69	1,838	1,268	24,821	26.7 K to 24.8 K (-6.89 %)
Jul 03 2012	ANTH	Anthera Pharmaceut ...	ORBIMED ADVISORS LLC	Director	Sell	S	0.73	1,283,300	942,071	0	1.3 M to 0 (-100.00 %)
Jul 02 2012	ANTH	Anthera Pharmaceut ...	HENNEY CHRISTOPHER S	Director	Buy	P	0.75	100,000	74,930	100,000	0 to 100 K
Jul 02 2012	ANTH	Anthera Pharmaceut ...	HENNEY CHRISTOPHER S	Director	Buy	P	0.75	100,000	74,930	202,429	102.4 K to 202.4 K (+97.63 %)
Jul 02 2012	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and CEO	Buy	P	0.76	20,000	15,200	645,125	625.1 K to 645.1 K (+3.20 %)
May 10 2012	ANTH	Anthera Pharmaceut ...	SPIEGELMAN DANIEL K	Director	Option Exercise	A	1.79	12,000	21,480	12,000
May 10 2012	ANTH	Anthera Pharmaceut ...	HEALY JAMES	Director	Option Exercise	A	1.79	12,000	21,480	12,000
May 10 2012	ANTH	Anthera Pharmaceut ...	Thompson Peter A.	Director	Option Exercise	A	1.79	12,000	21,480	12,000
May 10 2012	ANTH	Anthera Pharmaceut ...	DZIURZYNSKI BOGDAN	Director	Option Exercise	A	1.79	12,000	21,480	12,000
May 10 2012	ANTH	Anthera Pharmaceut ...	HENNEY CHRISTOPHER S	Director	Option Exercise	A	1.79	15,000	26,850	15,000
May 10 2012	ANTH	Anthera Pharmaceut ...	Thompson David E.	Director	Option Exercise	A	1.79	12,000	21,480	12,000
Apr 03 2012	ANTH	Anthera Pharmaceut ...	DZIURZYNSKI BOGDAN	Director	Option Exercise	A	2.21	25,000	55,250	25,000
Apr 03 2012	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and C.E.O ...	Option Exercise	A	2.21	175,000	386,750	175,000
Apr 03 2012	ANTH	Anthera Pharmaceut ...	KILFOIL GEORGINA	SVP,Product Dev.& P ...	Option Exercise	A	2.21	60,000	132,600	60,000
Apr 03 2012	ANTH	Anthera Pharmaceut ...	ODINK DEBRA	Chief Technology Of ...	Option Exercise	A	2.21	160,000	353,600	160,000
Apr 03 2012	ANTH	Anthera Pharmaceut ...	LOWE CHRISTOPHER P.	C.F.O. and C.B.O.	Option Exercise	A	2.21	80,000	176,800	80,000
Apr 03 2012	ANTH	Anthera Pharmaceut ...	Hislop Colin	Chief Medical Offic ...	Option Exercise	A	2.21	80,000	176,800	80,000
Mar 22 2012	ANTH	Anthera Pharmaceut ...	ORBIMED ADVISORS LLC	Director	Sell	S	2.40	1,306,700	3,140,131	1,283,300	2.6 M to 1.3 M (-50.45 %)
Mar 22 2012	ANTH	Anthera Pharmaceut ...	ORBIMED ADVISORS LLC	Director	Sell	S	2.87	125,000	358,313	2,590,000	2.7 M to 2.6 M (-4.60 %)
Mar 22 2012	ANTH	Anthera Pharmaceut ...	ORBIMED ADVISORS LLC	Director	Sell	S	2.90	116,800	338,638	2,715,000	2.8 M to 2.7 M (-4.12 %)
Mar 05 2012	ANTH	Anthera Pharmaceut ...	ODINK DEBRA	Chief Technology Of ...	Sell	S	6.57	2,000	13,140	26,659	28.7 K to 26.7 K (-6.98 %)
Feb 27 2012	ANTH	Anthera Pharmaceut ...	Hislop Colin	Chief Medical Offic ...	Option Exercise	M	0.26	40,000	10,400	50,447
Feb 27 2012	ANTH	Anthera Pharmaceut ...	Hislop Colin	Chief Medical Offic ...	Buy	M	0.26	40,000	10,400	79,519	39.5 K to 79.5 K (+101.22 %)
Feb 17 2012	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and C.E.O ...	Sell	S	7.84	15,000	117,600	625,125	640.1 K to 625.1 K (-2.34 %)
Feb 07 2012	ANTH	Anthera Pharmaceut ...	KILFOIL GEORGINA	SVP,Product Dev.& P ...	Grant	A	0.00	5,243	0	24,513	19.3 K to 24.5 K (+27.21 %)
Feb 06 2012	ANTH	Anthera Pharmaceut ...	ODINK DEBRA	Chief Technology Of ...	Grant	A	0.00	7,418	0	28,659	21.2 K to 28.7 K (+34.92 %)
Feb 06 2012	ANTH	Anthera Pharmaceut ...	Hislop Colin	Chief Medical Offic ...	Grant	A	0.00	9,923	0	39,519	29.6 K to 39.5 K (+33.53 %)
Feb 06 2012	ANTH	Anthera Pharmaceut ...	Hislop Colin	Chief Medical Offic ...	Sell	S	8.20	30,000	246,000	27,967	58 K to 28 K (-51.75 %)
Feb 06 2012	ANTH	Anthera Pharmaceut ...	LOWE CHRISTOPHER P.	C.F.O. and C.B.O.	Grant	A	0.00	18,845	0	49,996	31.2 K to 50 K (+60.50 %)
Feb 06 2012	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and Chief ...	Grant	A	0.00	37,984	0	79,755	41.8 K to 79.8 K (+90.93 %)
Feb 03 2012	ANTH	Anthera Pharmaceut ...	LOWE CHRISTOPHER P.	C.F.O. and C.B.O.	Sell	S	7.66	15,000	114,900	31,151	46.2 K to 31.2 K (-32.50 %)
Feb 03 2012	ANTH	Anthera Pharmaceut ...	ODINK DEBRA	Chief Technology Of ...	Sell	S	7.67	2,000	15,340	21,241	23.2 K to 21.2 K (-8.61 %)
Feb 02 2012	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and C.E.O ...	Option Exercise	M	0.26	20,000	5,200	262,826
Feb 02 2012	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and C.E.O ...	Buy	M	0.26	20,000	5,200	640,125	620.1 K to 640.1 K (+3.23 %)
Feb 02 2012	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and C.E.O ...	Gift	G	0.00	7,000	0	620,125	627.1 K to 620.1 K (-1.12 %)
Jan 31 2012	ANTH	Anthera Pharmaceut ...	HEALY JAMES	Director	Option Exercise	M	4.19	12,000	50,280	0
Jan 31 2012	ANTH	Anthera Pharmaceut ...	HEALY JAMES	Director	Sell	M	4.19	12,000	50,280	32,443	44.4 K to 32.4 K (-27.00 %)
Jan 19 2012	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and Chief ...	Sell	S	6.75	15,000	101,250	627,125	642.1 K to 627.1 K (-2.34 %)
Jan 12 2012	ANTH	Anthera Pharmaceut ...	ODINK DEBRA	Chief Technology Of ...	Sell	S	6.51	800	5,205	23,241	24 K to 23.2 K (-3.33 %)
Jan 10 2012	ANTH	Anthera Pharmaceut ...	ODINK DEBRA	Chief Technology Of ...	Sell	S	6.50	1,200	7,800	24,441	25.6 K to 24.4 K (-4.68 %)
Jan 03 2012	ANTH	Anthera Pharmaceut ...	HEALY JAMES	Director	Sell	S	6.23	280	1,743	44,969	45.2 K to 45 K (-0.62 %)
Jan 03 2012	ANTH	Anthera Pharmaceut ...	HEALY JAMES	Director	Sell	S	6.23	4,090	25,460	653,550	657.6 K to 653.6 K (-0.62 %)
Jan 03 2012	ANTH	Anthera Pharmaceut ...	HEALY JAMES	Director	Sell	S	6.23	20,630	128,422	3,298,684	3.3 M to 3.3 M (-0.62 %)
Jan 03 2012	ANTH	Anthera Pharmaceut ...	SOFINNOVA VENTURE PARTNERS VI ...	10% Owner	Sell	S	6.23	280	1,743	44,969	45.2 K to 45 K (-0.62 %)
Jan 03 2012	ANTH	Anthera Pharmaceut ...	SOFINNOVA VENTURE PARTNERS VI ...	10% Owner	Sell	S	6.23	4,090	25,460	653,550	657.6 K to 653.6 K (-0.62 %)
Jan 03 2012	ANTH	Anthera Pharmaceut ...	SOFINNOVA VENTURE PARTNERS VI ...	10% Owner	Sell	S	6.23	20,630	128,422	3,298,684	3.3 M to 3.3 M (-0.62 %)
Dec 23 2011	ANTH	Anthera Pharmaceut ...	HEALY JAMES	Director	Sell	S	6.22	280	1,743	45,249	45.5 K to 45.2 K (-0.61 %)
Dec 23 2011	ANTH	Anthera Pharmaceut ...	HEALY JAMES	Director	Sell	S	6.22	4,090	25,457	657,640	661.7 K to 657.6 K (-0.62 %)
Dec 23 2011	ANTH	Anthera Pharmaceut ...	HEALY JAMES	Director	Sell	S	6.22	20,630	128,405	3,319,314	3.3 M to 3.3 M (-0.62 %)
Dec 23 2011	ANTH	Anthera Pharmaceut ...	HEALY JAMES	Director	Sell	S	6.51	280	1,823	45,529	45.8 K to 45.5 K (-0.61 %)
Dec 23 2011	ANTH	Anthera Pharmaceut ...	HEALY JAMES	Director	Sell	S	6.51	4,090	26,629	661,730	665.8 K to 661.7 K (-0.61 %)
Dec 23 2011	ANTH	Anthera Pharmaceut ...	HEALY JAMES	Director	Sell	S	6.51	20,630	134,318	3,339,944	3.4 M to 3.3 M (-0.61 %)
Dec 23 2011	ANTH	Anthera Pharmaceut ...	SOFINNOVA VENTURE PARTNERS VI ...	10% Owner	Sell	S	6.22	280	1,743	45,249	45.5 K to 45.2 K (-0.61 %)
Dec 23 2011	ANTH	Anthera Pharmaceut ...	SOFINNOVA VENTURE PARTNERS VI ...	10% Owner	Sell	S	6.22	4,090	25,457	657,640	661.7 K to 657.6 K (-0.62 %)
Dec 23 2011	ANTH	Anthera Pharmaceut ...	SOFINNOVA VENTURE PARTNERS VI ...	10% Owner	Sell	S	6.22	20,630	128,405	3,319,314	3.3 M to 3.3 M (-0.62 %)
Dec 23 2011	ANTH	Anthera Pharmaceut ...	SOFINNOVA VENTURE PARTNERS VI ...	10% Owner	Sell	S	6.51	280	1,823	45,529	45.8 K to 45.5 K (-0.61 %)
Dec 23 2011	ANTH	Anthera Pharmaceut ...	SOFINNOVA VENTURE PARTNERS VI ...	10% Owner	Sell	S	6.51	4,090	26,629	661,730	665.8 K to 661.7 K (-0.61 %)
Dec 23 2011	ANTH	Anthera Pharmaceut ...	SOFINNOVA VENTURE PARTNERS VI ...	10% Owner	Sell	S	6.51	20,630	134,318	3,339,944	3.4 M to 3.3 M (-0.61 %)
Dec 16 2011	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and CEO	Sell	S	6.34	15,000	95,066	642,125	657.1 K to 642.1 K (-2.28 %)
Dec 13 2011	ANTH	Anthera Pharmaceut ...	ORBIMED ADVISORS LLC	Director	Sell	S	6.50	16,200	105,300	2,831,800	2.8 M to 2.8 M (-0.57 %)
Dec 13 2011	ANTH	Anthera Pharmaceut ...	ORBIMED ADVISORS LLC	Director	Sell	S	6.75	40,000	270,000	2,848,000	2.9 M to 2.8 M (-1.39 %)
Nov 21 2011	ANTH	Anthera Pharmaceut ...	Thompson David E.	Director	Gift	G	0.00	3,800	0	7,758	11.6 K to 7.8 K (-32.88 %)
Nov 18 2011	ANTH	Anthera Pharmaceut ...	ORBIMED ADVISORS LLC	Director	Sell	S	6.50	3,000	19,500	2,888,000	2.9 M to 2.9 M (-0.10 %)
Nov 18 2011	ANTH	Anthera Pharmaceut ...	ORBIMED ADVISORS LLC	Director	Sell	S	6.67	24,000	160,080	2,891,000	2.9 M to 2.9 M (-0.82 %)
Nov 18 2011	ANTH	Anthera Pharmaceut ...	ORBIMED ADVISORS LLC	Director	Sell	S	6.87	25,000	171,750	2,915,000	2.9 M to 2.9 M (-0.85 %)
Nov 17 2011	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and CEO	Sell	S	6.96	15,000	104,352	657,125	672.1 K to 657.1 K (-2.23 %)
Nov 17 2011	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and CEO	Sell	S	6.96	15,000	104,352	672,125	687.1 K to 672.1 K (-2.18 %)
Nov 17 2011	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and CEO	Gift	G	0.00	50,000	0	687,125	637.1 K to 687.1 K (+7.85 %)
Nov 17 2011	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and CEO	Gift	G	0.00	50,000	0	40,512	90.5 K to 40.5 K (-55.24 %)
Nov 15 2011	ANTH	Anthera Pharmaceut ...	ORBIMED ADVISORS LLC	Director	Sell	S	6.93	50,000	346,500	2,940,000	3 M to 2.9 M (-1.67 %)
Nov 15 2011	ANTH	Anthera Pharmaceut ...	ORBIMED ADVISORS LLC	Director	Sell	S	6.95	5,000	34,750	2,990,000	3 M to 3 M (-0.17 %)
Nov 15 2011	ANTH	Anthera Pharmaceut ...	ORBIMED ADVISORS LLC	Director	Sell	S	7.14	5,000	35,700	2,995,000	3 M to 3 M (-0.17 %)
Nov 10 2011	ANTH	Anthera Pharmaceut ...	Hislop Colin	Chief Medical Offic ...	Option Exercise	M	0.26	15,000	3,900	90,447
Nov 10 2011	ANTH	Anthera Pharmaceut ...	Hislop Colin	Chief Medical Offic ...	Sell	S	6.74	15,000	101,163	57,967	73 K to 58 K (-20.56 %)
Nov 10 2011	ANTH	Anthera Pharmaceut ...	Hislop Colin	Chief Medical Offic ...	Buy	M	0.26	15,000	3,900	72,967	58 K to 73 K (+25.88 %)
Nov 04 2011	ANTH	Anthera Pharmaceut ...	LOWE CHRISTOPHER P.	Chief Financial Off ...	Sell	S	6.88	15,000	103,236	46,151	61.2 K to 46.2 K (-24.53 %)
Oct 27 2011	ANTH	Anthera Pharmaceut ...	LOWE CHRISTOPHER P.	Chief Financial Off ...	Sell	S	7.07	4,637	32,784	0	4.6 K to 0 (-100.00 %)
Oct 25 2011	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and CEO	Sell	S	6.25	11,879	74,244	637,125	649 K to 637.1 K (-1.83 %)
Oct 25 2011	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and CEO	Sell	S	6.25	11,356	70,975	649,004	660.4 K to 649 K (-1.72 %)
Oct 20 2011	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and CEO	Sell	S	6.25	6,745	42,156	660,360	667.1 K to 660.4 K (-1.01 %)
Aug 09 2011	ANTH	Anthera Pharmaceut ...	LOWE CHRISTOPHER P.	Chief Financial Off ...	Option Exercise	M	1.34	10,000	13,400	64,886
Aug 09 2011	ANTH	Anthera Pharmaceut ...	LOWE CHRISTOPHER P.	Chief Financial Off ...	Buy	M	1.34	10,000	13,400	61,151	51.2 K to 61.2 K (+19.55 %)
Aug 09 2011	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and CEO	Option Exercise	M	0.26	50,000	13,000	282,826
Aug 09 2011	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and CEO	Buy	M	0.26	50,000	13,000	90,512	40.5 K to 90.5 K (+123.42 %)
Aug 04 2011	ANTH	Anthera Pharmaceut ...	LOWE CHRISTOPHER P.	Chief Financial Off ...	Sell	S	6.88	14,600	100,432	51,151	65.8 K to 51.2 K (-22.20 %)
Aug 04 2011	ANTH	Anthera Pharmaceut ...	LOWE CHRISTOPHER P.	Chief Financial Off ...	Sell	S	7.93	300	2,378	4,637	4.9 K to 4.6 K (-6.08 %)
Aug 04 2011	ANTH	Anthera Pharmaceut ...	LOWE CHRISTOPHER P.	Chief Financial Off ...	Sell	S	7.28	4,700	34,193	4,937	9.6 K to 4.9 K (-48.77 %)
Jul 18 2011	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and CEO	Sell	S	7.95	15,000	119,258	667,125	682.1 K to 667.1 K (-2.20 %)
Jul 14 2011	ANTH	Anthera Pharmaceut ...	Hislop Colin	Chief Medical Offic ...	Option Exercise	M	0.26	15,000	3,900	105,447
Jul 14 2011	ANTH	Anthera Pharmaceut ...	Hislop Colin	Chief Medical Offic ...	Buy	M	0.26	15,000	3,900	57,967	43 K to 58 K (+34.91 %)
Jul 11 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Option Exercise	M	4.19	9,000	37,710	3,000
Jul 11 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Option Exercise	M	1.51	3,894	5,880	1,947
Jul 11 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Option Exercise	M	1.34	11,560	15,490	3,042
Jul 11 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Buy	M	4.19	7,200	30,168	5,357,528	5.4 M to 5.4 M (+0.13 %)
Jul 11 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Buy	M	1.51	3,115	4,704	5,350,328	5.3 M to 5.4 M (+0.06 %)
Jul 11 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Buy	M	1.34	9,248	12,392	5,347,213	5.3 M to 5.3 M (+0.17 %)
Jul 05 2011	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and CEO	Payment of Exercise	F	8.17	48,500	396,245	40,512	89 K to 40.5 K (-54.49 %)
Jul 05 2011	ANTH	Anthera Pharmaceut ...	LOWE CHRISTOPHER P.	Chief Financial Off ...	Payment of Exercise	F	8.17	23,500	191,995	65,751	89.3 K to 65.8 K (-26.33 %)
Jul 05 2011	ANTH	Anthera Pharmaceut ...	KILFOIL GEORGINA	SVP, Prod. Dev. & P ...	Payment of Exercise	F	8.17	5,625	45,956	16,875	22.5 K to 16.9 K (-25.00 %)
Jul 05 2011	ANTH	Anthera Pharmaceut ...	Hislop Colin	Chief Medical Offic ...	Payment of Exercise	F	8.17	17,500	142,975	42,967	60.5 K to 43 K (-28.94 %)
Jul 05 2011	ANTH	Anthera Pharmaceut ...	Thompson Peter A.	Director	Option Exercise	A	8.17	25,000	204,250	25,000
Jul 05 2011	ANTH	Anthera Pharmaceut ...	Thompson Peter A.	Director	Option Exercise	A	8.17	12,000	98,040	12,000
Jul 05 2011	ANTH	Anthera Pharmaceut ...	ODINK DEBRA	VP, Pharmaceutical ...	Payment of Exercise	F	8.17	3,670	29,984	25,641	29.3 K to 25.6 K (-12.52 %)
Jul 05 2011	ANTH	Anthera Pharmaceut ...	Thompson David E.	Director	Option Exercise	A	8.17	12,000	98,040	12,000
Jul 05 2011	ANTH	Anthera Pharmaceut ...	SPIEGELMAN DANIEL K	Director	Option Exercise	A	8.17	12,000	98,040	12,000
Jul 05 2011	ANTH	Anthera Pharmaceut ...	Santel Donald J	Director	Option Exercise	A	8.17	12,000	98,040	12,000
Jul 05 2011	ANTH	Anthera Pharmaceut ...	HENNEY CHRISTOPHER S	Director	Option Exercise	A	8.17	15,000	122,550	15,000
Jul 05 2011	ANTH	Anthera Pharmaceut ...	HEALY JAMES	Director	Option Exercise	A	8.17	12,000	98,040	12,000
Jun 30 2011	ANTH	Anthera Pharmaceut ...	Hislop Colin	Chief Medical Offic ...	Option Exercise	M	0.26	10,000	2,600	120,447
Jun 30 2011	ANTH	Anthera Pharmaceut ...	Hislop Colin	Chief Medical Offic ...	Buy	M	0.26	10,000	2,600	60,062	50.1 K to 60.1 K (+19.98 %)
Jun 22 2011	ANTH	Anthera Pharmaceut ...	LOWE CHRISTOPHER P.	Chief Financial Off ...	Option Exercise	M	1.51	17,080	25,791	6,284
Jun 22 2011	ANTH	Anthera Pharmaceut ...	LOWE CHRISTOPHER P.	Chief Financial Off ...	Option Exercise	M	0.14	2,920	409	0
Jun 22 2011	ANTH	Anthera Pharmaceut ...	LOWE CHRISTOPHER P.	Chief Financial Off ...	Buy	M	1.51	17,080	25,791	87,645	70.6 K to 87.6 K (+24.20 %)
Jun 22 2011	ANTH	Anthera Pharmaceut ...	LOWE CHRISTOPHER P.	Chief Financial Off ...	Buy	M	0.14	2,920	409	70,565	67.6 K to 70.6 K (+4.32 %)
Jun 20 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.67	10	87	17,611	17.6 K to 17.6 K (-0.06 %)
Jun 20 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.67	281	2,436	484,152	484.4 K to 484.2 K (-0.06 %)
Jun 20 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.67	2,809	24,354	4,836,202	4.8 M to 4.8 M (-0.06 %)
Jun 17 2011	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and CEO	Sell	S	8.30	15,000	124,539	682,125	697.1 K to 682.1 K (-2.15 %)
Jun 17 2011	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and CEO	Gift	G	0.00	5,122	0	697,125	692 K to 697.1 K (+0.74 %)
Jun 17 2011	ANTH	Anthera Pharmaceut ...	TRUEX PAUL F	President and CEO	Gift	G	0.00	5,122	0	86,000	91.1 K to 86 K (-5.62 %)
Jun 15 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.81	2	18	17,621	17.6 K to 17.6 K (-0.01 %)
Jun 15 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.81	63	555	484,433	484.5 K to 484.4 K (-0.01 %)
Jun 15 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.81	634	5,586	4,839,011	4.8 M to 4.8 M (-0.01 %)
Jun 15 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.80	4	35	17,624	17.6 K to 17.6 K (-0.02 %)
Jun 15 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.80	118	1,038	484,496	484.6 K to 484.5 K (-0.02 %)
Jun 15 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.80	1,178	10,366	4,839,645	4.8 M to 4.8 M (-0.02 %)
Jun 10 2011	ANTH	Anthera Pharmaceut ...	ORBIMED ADVISORS LLC	Director	Sell	S	8.18	30,000	245,400	3,000,000	3 M to 3 M (-0.99 %)
Jun 10 2011	ANTH	Anthera Pharmaceut ...	ORBIMED ADVISORS LLC	Director	Sell	S	8.11	37,000	300,070	3,030,000	3.1 M to 3 M (-1.21 %)
Jun 10 2011	ANTH	Anthera Pharmaceut ...	ORBIMED ADVISORS LLC	Director	Sell	S	8.02	33,000	264,660	3,067,000	3.1 M to 3.1 M (-1.06 %)
May 31 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.60	16	138	17,628	17.6 K to 17.6 K (-0.09 %)
May 31 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.60	435	3,741	484,614	485 K to 484.6 K (-0.09 %)
May 31 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.60	4,349	37,401	4,840,823	4.8 M to 4.8 M (-0.09 %)
May 27 2011	ANTH	Anthera Pharmaceut ...	ORBIMED ADVISORS LLC	Director	Sell	S	8.53	34,200	291,726	0	34.2 K to 0 (-100.00 %)
May 27 2011	ANTH	Anthera Pharmaceut ...	ORBIMED ADVISORS LLC	Director	Sell	S	8.65	4,800	41,520	0	4.8 K to 0 (-100.00 %)
May 25 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.67	108	936	17,644	17.8 K to 17.6 K (-0.61 %)
May 25 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.67	2,970	25,750	485,049	488 K to 485 K (-0.61 %)
May 25 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.67	29,672	257,256	4,845,172	4.9 M to 4.8 M (-0.61 %)
May 25 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.42	172	1,448	17,752	17.9 K to 17.8 K (-0.96 %)
May 25 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.42	4,734	39,860	488,019	492.8 K to 488 K (-0.96 %)
May 25 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.42	47,290	398,182	4,874,844	4.9 M to 4.9 M (-0.96 %)
May 25 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.18	88	720	17,924	18 K to 17.9 K (-0.49 %)
May 25 2011	ANTH	Anthera Pharmaceut ...	VANTAGEPOINT VENTURE ASSOCIATE ...	10% Owner	Sell	S	8.18	2,422	19,812	492,753	495.2 K to 492.8 K (-0.49 %)

Page: < prev 1 2 3 4 next >